Details for Patent: 5,972,967
✉ Email this page to a colleague
Summary for Patent: 5,972,967
Title: | Compositions for inhibiting platelet aggregation |
Abstract: | The invention is a pharmaceutical composition for intravenous administration to a patient comprising a) a pharmaceutically effective amount of 2-S-(n-Butylsulfonylamino)-3-[4-(4-(piperidin-4-yl)butyloxy)phenyl]propion ic acid; b) a pharmaceutically acceptable amount of a citrate buffer effective to provide a pH of between about 5 and 7; and c) a pharmaceutically acceptable amount of a tonicity adjusting agent effective to make the formulation substantially isotonic with the osmotic pressure of the biological system of the patient. |
Inventor(s): | Gelotte; Karl M. (North Wales, PA) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 08/965,922 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Use; |
Drugs Protected by US Patent 5,972,967
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,972,967
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 004223 | ⤷ Sign Up | |||
Austria | 213648 | ⤷ Sign Up | |||
Australia | 712755 | ⤷ Sign Up | |||
Australia | 7718996 | ⤷ Sign Up | |||
Bulgaria | 102405 | ⤷ Sign Up | |||
Bulgaria | 63623 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |